[go: up one dir, main page]

MXPA05001469A - Uso de extracto de germen de trigo fermentado como agente anti-inflamatorio. - Google Patents

Uso de extracto de germen de trigo fermentado como agente anti-inflamatorio.

Info

Publication number
MXPA05001469A
MXPA05001469A MXPA05001469A MXPA05001469A MXPA05001469A MX PA05001469 A MXPA05001469 A MX PA05001469A MX PA05001469 A MXPA05001469 A MX PA05001469A MX PA05001469 A MXPA05001469 A MX PA05001469A MX PA05001469 A MXPA05001469 A MX PA05001469A
Authority
MX
Mexico
Prior art keywords
wheat germ
inflammatory agent
germ extract
fermented wheat
avemar
Prior art date
Application number
MXPA05001469A
Other languages
English (en)
Inventor
Mate Hidvegi
Original Assignee
Mate Hidvegi Y Akos Resetar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mate Hidvegi Y Akos Resetar filed Critical Mate Hidvegi Y Akos Resetar
Publication of MXPA05001469A publication Critical patent/MXPA05001469A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a un nuevo uso terapeutico de un extracto de germen de trigo fermentado bajo el nombre comercial Avemar(r), mas especificamente para el uso de Avemar(r) para la fabricacion de un medicamento util como agente anti-inflamatorio para prevenir o tratar o aliviar condiciones inflamatorias, particularmente artritis.
MXPA05001469A 2002-08-09 2003-08-08 Uso de extracto de germen de trigo fermentado como agente anti-inflamatorio. MXPA05001469A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0202638A HUP0202638A3 (en) 2002-08-09 2002-08-09 Use of fermented wheat-germ extract for preparation of antiphlogistic compositions
PCT/HU2003/000065 WO2004014406A1 (en) 2002-08-09 2003-08-08 Use of fermented wheat germ extract as anti-inflammatory agent

Publications (1)

Publication Number Publication Date
MXPA05001469A true MXPA05001469A (es) 2005-06-06

Family

ID=89980690

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05001469A MXPA05001469A (es) 2002-08-09 2003-08-08 Uso de extracto de germen de trigo fermentado como agente anti-inflamatorio.

Country Status (15)

Country Link
EP (1) EP1536809A1 (es)
JP (1) JP2006501214A (es)
KR (1) KR20050059066A (es)
CN (1) CN1674924A (es)
AU (1) AU2003255854A1 (es)
BR (1) BR0313589A (es)
CA (1) CA2494744A1 (es)
EA (1) EA007844B1 (es)
HR (1) HRP20050114A2 (es)
HU (1) HUP0202638A3 (es)
IL (1) IL166732A0 (es)
MX (1) MXPA05001469A (es)
NO (1) NO20051168L (es)
PL (1) PL375391A1 (es)
WO (1) WO2004014406A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908998A1 (fr) * 2006-11-24 2008-05-30 Bao Quoc Ho Nouveau produit enzymatique et son utilisation.
HUP0900614A2 (en) * 2009-09-29 2011-05-30 Mate Dr Hidvegi Preparation comprising dehydrated, fermented material with amorphous crystaline structure and process for its production
US9480725B2 (en) 2009-05-20 2016-11-01 The Regents Of The University Of California Fermented wheat germ proteins (FWGP) for the treatment of cancer
US20120164132A1 (en) * 2010-08-02 2012-06-28 Mate Hidvegi Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
GB201108560D0 (en) 2011-05-20 2011-07-06 3 Ch Ltd Use of fermented wheat germ in the treatment of inflammatory bowel disease
GB201110746D0 (en) 2011-06-23 2011-08-10 Biropharma Uk Ltd Wheat germ derived material
JP6115995B2 (ja) * 2013-04-24 2017-04-19 株式会社日清製粉グループ本社 非酵素的糖化反応抑制剤
CN104381450A (zh) * 2014-10-15 2015-03-04 张士远 治疗胃粘膜损伤的保健牛奶及其制备方法
WO2017196048A1 (ko) * 2016-05-11 2017-11-16 씨제이제일제당 (주) 밀배아 발효물의 추출물을 유효성분으로 함유하는 피부 주름 개선 외용제 조성물
WO2018056600A1 (ko) * 2016-09-23 2018-03-29 씨제이제일제당 (주) 밀배아 발효물의 추출물을 유효성분으로 함유하는 피부진정 외용제 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242537A (ja) * 1994-03-04 1995-09-19 Kibun Foods Inc 抗炎症活性物質の製造方法および抗炎症剤
JPH08337536A (ja) * 1995-06-14 1996-12-24 Asahi Breweries Ltd 抗活性酸素作用剤並びにこれを有効成分とする抗活性酸素剤、化粧料、食品及び医薬品
HU223344B1 (hu) * 1997-08-13 2004-06-28 Máté Hidvégi Immunstimuláns és metasztázist gátló fermentált, szárított anyag, ezt tartalmazó gyógyszerkészítmények, eljárás az előállítására és alkalmazásai

Also Published As

Publication number Publication date
WO2004014406A1 (en) 2004-02-19
EP1536809A1 (en) 2005-06-08
CN1674924A (zh) 2005-09-28
HUP0202638A2 (hu) 2004-06-28
HUP0202638A3 (en) 2007-08-28
CA2494744A1 (en) 2004-02-19
IL166732A0 (en) 2006-01-15
PL375391A1 (en) 2005-11-28
HU0202638D0 (es) 2002-10-28
EA007844B1 (ru) 2007-02-27
JP2006501214A (ja) 2006-01-12
EA200500326A1 (ru) 2005-06-30
BR0313589A (pt) 2005-07-12
KR20050059066A (ko) 2005-06-17
AU2003255854A1 (en) 2004-02-25
NO20051168L (no) 2005-03-04
HRP20050114A2 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TWI345979B (en) Topical pharmaceutical compositions for the treatment of dermatitis
GEP20104994B (en) Tetrahydroindolone and tetrahydroindazolone derivatives
IL187328A (en) N- Methyl-2-Fluoro- {4- [3- (4-Cyano-3-Trifluoromethylphenyl) -5,5-Dimethyl-4-Oxo-2-Theoxo-Imidazolidin-1-Ill]} Benzamide, Pharmaceuticals Containing It and its use for drug preparation
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
DE602004011394D1 (en) Thiazolderivate
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
AUPS057102A0 (en) Compositions and methods for treatment of skin disorders
TW200621765A (en) Substituted phenylaminothiazoles and their use
MX2007005649A (es) Carboxiamidas de azaindol.
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
IL172773A0 (en) Formulations for the treatment of arhritis conditions
MXPA05001469A (es) Uso de extracto de germen de trigo fermentado como agente anti-inflamatorio.
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
AU3321002A (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence